| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Aug 09, 2024 | Aug 12, 2024 | Mack Gene CFO Interim CEO | Buy | Gain Therapeutics, Inc. | GANX | $1.01 | $14,544 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.